Elastrin Therapeutics announced it raised $50,000 in an initial filing from an offering of $500,000

Company

Location

About

Elastrin Therapeutics Inc. is a biotech startup set to rejuvenate cardiovascular diseases. Our mission is to develop innovative therapies that target the root causes of cardiovascular conditions, providing new hope for patients and their families. We are dedicated to advancing the field of biotechnology through cutting-edge research and collaborative partnerships.